$MSMY. The Corporate News Update is an example of what to expect from the new CEO of MSMY Steven Mazurek He has been diligently cleaning house to move forward with the growth of CBD Liquid Labs. He has stated his conviction that shareholders are important to him and will keep them informed of progress as the company continues to grow as a manufacturer in the CBD industry. We should see a steady stream of news through tweets and PRs.
$MSMY, MC Endeavors, CBD Liquid Labs Corporate Update
CEO Steven Mazurek Updates Shareholders on Significant Changes to the Corporate Landscape
PRESS RELEASE UPDATED: FEB 7, 2020 14:35 EST
ALISO VIEJO, Calif., February 7, 2020 (Newswire.com) -MC Endeavors, Inc. / CBD Liquid Labs (PINKSHEETS: MSMY)
Mr. Mazurek is excited to announce the change of control has been completed and Mr. Stippick is no longer a part of MSMY/CBD Liquid Labs.
Corporate Updates:
The Special Preferred A Share has been signed over from John Stippick to Steven Mazurek, signatures have been Medallion Guaranteed and the certificate shipped to the Transfer Agent to be reissued
Company has accepted Mr. Stippicks signed letter of Resignation as an Officer and Director of MSMY
35 million common shares in the name of Mr. Stippick have been canceled and the remaining 14 million are being reassigned
Current Issued and Outstanding Common shares will now total 601,545,809 Company has canceled convertible notes to Mr. Stippick for $115,668 and $45,000
Mr. Mazurek is in possession of a MSMY cert for 20 million preferred shares of MGON
All related assets and liabilities for Room 21 Media are being transferred to Mr. Stippick
Trusted business legal firm (Winter LLP) attorneys working on Reverse Merger and Name / Symbol change paperwork In the next couple of weeks,
the Company plans to release an exciting video Sales and Marketing Update outlining the plan for growth in 202021 as well as announcing some innovative new products and sales presentation materials for our clients.
About Eclipse Liquids/CBD Liquid Labs
Founded in 2013, Eclipse Liquids is one of only 34 AEMSA certified and FDA registered clean room laboratories and production facilities for eLiquid private label manufacturing in the world.
Through years of honing our manufacturing processes, developing and innovating new products and building a loyal and dedicated staff, Eclipse has grownto become a leader in the CBD Product manufacturing industry.
Specializing in private label premium CBD products serving the needs of small-scale businesses to large multi-national companies.
The Company offers a broad range of capabilities, from custom recipe development with full production and manufacturing, to confidential private labeling of your branded CBD products.
Safe Harbor Statement In addition to historical information, this press release may contain statements that constitute forward-looking statements within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995.
Forward-looking statements contained in this press release include the intent, belief, or expectations of the Company and members of its management team with respect to the Companys future business operations and the assumptions upon which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance, and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements.
Factors that could cause these differences include, but are not limited to, failure to complete anticipated sales under negotiations, lack of revenue growth, client discontinuances, failure to realize improvements in performance, efficiency and profitability, and adverse developments with respect to litigation or increased litigation costs, the operation or performance of the Companys business units or the market price of its common stock.
Additional factors that would cause actual results to differ materially from those contemplated within this press release can also be found on the Companys website. The Company disclaims any responsibility to update any forward-looking statements.
Market Data 
Markets 
AI
